Detalles de la búsqueda
1.
Inclisiran in individuals with diabetes or obesity: Post hoc pooled analyses of the ORION-9, ORION-10 and ORION-11 Phase 3 randomized trials.
Diabetes Obes Metab
; 2024 May 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38757725
2.
Efficacy and Safety of Inclisiran in Patients with Polyvascular Disease: Pooled, Post Hoc Analysis of the ORION-9, ORION-10, and ORION-11 Phase 3 Randomized Controlled Trials.
Cardiovasc Drugs Ther
; 2022 Dec 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-36550348
3.
A pre-specified statistical analysis plan for the VERIFY study: Vildagliptin efficacy in combination with metformin for early treatment of T2DM.
Diabetes Obes Metab
; 21(10): 2240-2247, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31144427
4.
BGG492 as an adjunctive treatment in patients with partial-onset seizures: A 12-week, randomized, double-blind, placebo-controlled, phase II dose-titration study with an open-label extension.
Epilepsia
; 58(7): 1217-1226, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28500678
5.
Limitations of serum ferritin to predict liver iron concentration responses to deferasirox therapy in patients with transfusion-dependent thalassaemia.
Eur J Haematol
; 98(3): 280-288, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-27859648
6.
Long-term safety and efficacy of deferasirox in young pediatric patients with transfusional hemosiderosis: Results from a 5-year observational study (ENTRUST).
Pediatr Blood Cancer
; 64(9)2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28296163
7.
Utility of labile plasma iron and transferrin saturation in addition to serum ferritin as iron overload markers in different underlying anemias before and after deferasirox treatment.
Eur J Haematol
; 96(1): 19-26, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25691036
8.
Predicting serum ferritin levels in patients with iron overload treated with the film-coated tablet of deferasirox during the ECLIPSE study.
Am J Hematol
; 94(1): E15-E17, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30346059
9.
Influence of patient-reported outcomes on the treatment effect of deferasirox film-coated and dispersible tablet formulations in the ECLIPSE trial: A post hoc mediation analysis.
Am J Hematol
; 94(4): E96-E99, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30663129
10.
Renal safety under long-course deferasirox therapy in iron overloaded transfusion-dependent ß-thalassemia and other anemias.
Am J Hematol
; 93(7): E172-E175, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29675847
11.
Efficacy and safety of inclisiran in patients with cerebrovascular disease: ORION-9, ORION-10, and ORION-11.
Am J Prev Cardiol
; 14: 100503, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37252442
12.
Inclisiran in patients with prior myocardial infarction: A post hoc pooled analysis of the ORION-10 and ORION-11 Phase 3 randomised trials.
Atherosclerosis
; 386: 117354, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38016401
13.
Cardiovascular Outcomes in De Novo Kidney Transplant Recipients Receiving Everolimus and Reduced Calcineurin Inhibitor or Standard Triple Therapy: 24-month Post Hoc Analysis From TRANSFORM Study.
Transplantation
; 107(7): 1593-1604, 2023 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36959121
14.
New regulators of Drosophila eye development identified from temporal transcriptome changes.
Genetics
; 217(4)2021 04 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33681970
15.
The Effects of Graded Levels of Calorie Restriction XV: Phase Space Attractors Reveal Distinct Behavioral Phenotypes.
J Gerontol A Biol Sci Med Sci
; 75(5): 858-866, 2020 04 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-32128585
16.
COMPARZ Post Hoc Analysis: Characterizing Pazopanib Responders With Advanced Renal Cell Carcinoma.
Clin Genitourin Cancer
; 17(6): 425-435.e4, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31601514
17.
Safety of pazopanib and sunitinib in treatment-naive patients with metastatic renal cell carcinoma: Asian versus non-Asian subgroup analysis of the COMPARZ trial.
J Hematol Oncol
; 11(1): 69, 2018 05 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-29788981
18.
The effects of graded levels of calorie restriction: VIII. Impact of short term calorie and protein restriction on basal metabolic rate in the C57BL/6 mouse.
Oncotarget
; 8(11): 17453-17474, 2017 Mar 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-28193912
19.
Negative regulation of DNMT3A de novo DNA methylation by frequently overexpressed UHRF family proteins as a mechanism for widespread DNA hypomethylation in cancer.
Cell Discov
; 2: 16007, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27462454
20.
The effects of graded levels of calorie restriction: II. Impact of short term calorie and protein restriction on circulating hormone levels, glucose homeostasis and oxidative stress in male C57BL/6 mice.
Oncotarget
; 6(27): 23213-37, 2015 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26061745